Dr. Laport is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Genentech/Roche
One DNA Way
South San Francisco, CA 94080Phone+1 650-387-7276- Is this information wrong?
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1994 - 1997
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1993 - 1994
- University of ChicagoResidency, Internal Medicine, 1990 - 1993
- McGovern Medical School at UTHealthClass of 1990
- Baylor UniversityBA, Psychology, 1982 - 1986
Certifications & Licensure
- CA State Medical License 1993 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
- Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) Start of enrollment: 2002 May 01
- Haploid Allogeneic Transplant Using the CliniMACS System Start of enrollment: 2001 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsAutologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.Matthew J. Frank, Michael S. Khodadoust, Debra K. Czerwinski, Ole Audun Werner Haabeth, Michael P. Chu, David B. Miklos, Ranjana H. Advani, Ash A. Alizadeh, Neel K. Gu...> ;The Journal of Experimental Medicine. 2020 Sep 7
- 130 citationsAdenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell CancerLawrence Fong, Andrew Hotson, John D. Powderly, Mario Sznol, Rebecca S. Heist, Toni K. Choueiri, Saby George, Brett G.M. Hughes, Matthew D. Hellmann, Dale R. Shepard, ...> ;Cancer Discovery. 2020 Jan 1
- 14 citationsDonor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.Rupa Narayan, Jonathan Benjamin, Omid Shah, Lu Tian, Keri Tate, Randall Armstrong, Bryan J. Xie, Robert Lowsky, Ginna G. Laport, Robert S. Negrin, Everett Meyer> ;Biology of Blood and Marrow Transplantation. 2019 Jul 1
- Join now to see all
Lectures
- Phase 1/1b multicenter trial of TPST-1120, a peroxisome proliferator-activated receptor alpha (PPARα) antagonist as a single agent (SA) or in combination in patients w...ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- Industry Careers61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- 2012 Highlights of ASH in North America (Las Vegas, NV)American Society of Hematology (ASH), Las Vegas, Nevada - 1/27/2012
Press Mentions
- Epkinly (Epcoritamab) Approved as First Bispecific Antibody for Most Common Non-Hodgkin’s LymphomaMay 25th, 2023
- Interview About New Follicular Lymphoma Drug Lunsumio with Genentech’s Dr. Ginna LaportFebruary 24th, 2023
- Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha AntagonistMay 16th, 2019
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: